News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major headlines emerged in the past hour; news flow was thin.
  • Global equity indices traded flat with little net movement.
  • U.S. Treasury yields showed minimal change across maturities.
  • Oil and gold prices were largely unchanged during the hour.
  • No significant economic data releases or central bank comments were published.
  • No new geopolitical or major corporate developments reported in the last hour.

Latest Articles

MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development

MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development

MaxCyte, Inc. announced a technology license partnership with Genentech to provide access to its ExPERT GTx® platform and other technologies to support cell therapy programs from research through manufacturing. This partnership highlights MaxCyte's role in enabling next-generation cell therapies with integrated cell engineering and gene editing tec…

VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services

VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services

VivoSim Labs, a US-based provider of human 3D tissue models for drug toxicology and efficacy testing, announced its first commercial sales in China through its local distributor. Securing engagements with leading Chinese biotech and pharmaceutical firms marks a significant step in VivoSim’s Asia-Pacific expansion. The company offers advanced New Ap…

Logistics Division Hyper-Growth (+80% CAGR) Unlocks Multi-Year Run Rate — Accelerating CLIK’s High-Margin Care U Expansion & Strategic Spin-Off

Logistics Division Hyper-Growth (+80% CAGR) Unlocks Multi-Year Run Rate — Accelerating CLIK’s High-Margin Care U Expansion & Strategic Spin-Off

Click Holdings Limited reported exceptional growth in its logistics division, with an 80% compound annual growth rate from FY2024 to FY2026, reaching monthly revenues of HK$4.37 million by June 2026. This growth is driving strong cash flows that support the expansion of its high-margin Care U senior care network and backing the planned spin-off and…

Genius Group Launches Full AI-Powered Product Suite, Building on 147% Year-on-Year Revenue Growth in H1 2026.

Genius Group Launches Full AI-Powered Product Suite, Building on 147% Year-on-Year Revenue Growth in H1 2026.

Genius Group Limited (NYSE: GNS), a global AI-powered education company, has launched Genius OS, a full suite of AI agent-driven products integrating education, acceleration, and productivity solutions across K-12 school systems, entrepreneur and investor academies, and innovative community models. Building on robust growth with 147% year-on-year r…

CVG Announces Second Quarter 2026 Earnings Call

CVG Announces Second Quarter 2026 Earnings Call

Commercial Vehicle Group, Inc. (NASDAQ: CVGI) announced its quarterly earnings conference call to discuss second quarter 2026 financial results, scheduled for August 4, 2026. The company will release a press release and presentation prior to the call. CVGI is a global provider of systems, assemblies, and components to commercial vehicle and electri…

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Cadrenal Therapeutics has aligned its cardiac critical care portfolio into a focused franchise and initiated partnering discussions for its late-stage assets including CAD-1005, frunexian, and tecarfarin. Promising Phase 2 data for CAD-1005 indicated a significant reduction in thrombotic events, bolstering the company’s strategy to leverage partner…

Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel

Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel

Verrica Pharmaceuticals Inc., a US-based dermatological therapeutics company, announced an exclusive distribution, marketing, and supply agreement with Medomie Pharma Ltd. for the commercialization of YCANTH®, a prescription treatment for molluscum contagiosum, in Israel. Under the agreement, Medomie will seek regulatory approvals and distribute th…

Rezolve Ai Brings Agentic Commerce Infrastructure to Zilch’s Payments Platform Serving Nearly 6 Million Customers

Rezolve Ai Brings Agentic Commerce Infrastructure to Zilch’s Payments Platform Serving Nearly 6 Million Customers

Rezolve Ai announced a strategic partnership with Zilch, a UK fintech unicorn, to embed Rezolve Ai's agentic commerce infrastructure into Zilch's payment platform via the Reward platform. This integration aims to provide personalized retailer engagement for nearly 6 million customers, enhance consumer value from everyday spending, and drive signifi…

ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology

ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology

ASP Isotopes Inc.'s subsidiary Quantum Leap Energy has entered a research agreement with Texas A&M Engineering Experiment Station to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6), critical to the nuclear fuel enrichment process. This collaboration aims to improve production efficiency, reduce costs, and sup…

Business Insider Launches Standalone FAST Channel, Partners with Magnite’s SpringServe for Next Phase of Streaming Growth

Business Insider Launches Standalone FAST Channel, Partners with Magnite’s SpringServe for Next Phase of Streaming Growth

Magnite announced that Business Insider has selected its SpringServe video platform to power ad serving and programmatic monetization of its new standalone FAST connected TV (CTV) channel. This move extends Business Insider’s premium video content to third-party platforms, aiming to deepen audience and advertiser engagement within the streaming eco…

Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

Rhythm Pharmaceuticals, a commercial-stage biopharmaceutical company specializing in treatments for rare neuroendocrine diseases, announced it will report its Q2 2026 financial results and host a conference call on August 4, 2026. The company’s lead drug, IMCIVREE (setmelanotide), is FDA-approved for treatment of obesity related to specific genetic…

Enphase Energy Unlocks Backup and Expandable Storage for Existing IQ Battery Customers Across Europe

Enphase Energy Unlocks Backup and Expandable Storage for Existing IQ Battery Customers Across Europe

Enphase Energy announced a new upgrade for European homeowners with existing second-generation IQ Battery systems, allowing them to add backup power and expand their storage capacity using new Enphase products without replacing current batteries. This upgrade enhances energy independence, supports increasing household electricity demands such as EV…

VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

VYNE Therapeutics announced a 1-for-50 reverse stock split in connection with its proposed merger with Yarrow Bioscience, expected to close around July 24, 2026. Post-merger, the combined company will trade under the ticker YARW on Nasdaq. VYNE also provided an update on a special cash dividend of $17.3 million payable to stockholders before the re…

Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care

Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care

Smith+Nephew has introduced ASC Solutions, an expanded enterprise strategy focused on ambulatory surgery centers (ASCs) to support cost optimization, quality, and outcome performance. The initiative includes the ASC ONE delivery model, integrating a network of partners to streamline ASC development and operations, providing a unified customer exper…

CISO Global Advances AI Software-Led Cybersecurity Strategy with FedRAMP-Certified TiGRIS GRC Platform

CISO Global Advances AI Software-Led Cybersecurity Strategy with FedRAMP-Certified TiGRIS GRC Platform

CISO Global, Inc. announced the expansion and automation of its TiGRIS governance, risk, and compliance (GRC) platform, which is FedRAMP-certified and designed for complex regulatory environments. The company plans to integrate generative AI capabilities to improve compliance intelligence and risk visibility. This development marks a key step in CI…